Lenvatinib
| Catalog Number | Pack Size | List Price* | Quantity | |
|---|---|---|---|---|
| HY-10981-5MG | 5 mg | 77,00 | Add | |
| HY-10981-1ML | 10mM/1mL | 83,00 | Add | |
| HY-10981-10MG | 10 mg | 102,00 | Add | |
| HY-10981-50MG | 50 mg | 204,00 | Add | |
| HY-10981-100MG | 100 mg | 302,00 | Add | |
| HY-10981-S-1ST | Sample | Inquire |
* CHF, excl. 8.1% VAT and shipping costs
Product Description
Best price guarantee – we offer you the lowest price in Switzerland. Please contact us for a quote if needed.
Lenvatinib (E7080) is an oral, multi-targeted tyrosine kinase inhibitor that inhibits VEGFR1-3, FGFR1-4, PDGFR, KIT, and RET, shows potent antitumor activities[1][2].
| Category | Biochemicals |
| Supplier | MedChem Express |
| Regulatory Status | RUO |
| Research Field | Cancer, Protein Tyrosine Kinase/RTK |
| Format | Solubility: DMSO : ≥ 12.78 mg/mL |
| Grade | Clinical information: Launched |
| Purity | 99.84% |
| Molecular Formula | C21H19ClN4O4 |
| Molecular Weight | 426.85 |
| CAS-Number | 417716-92-8 |
| Storage Conditions | -20°C, 3 years; 4°C, 2 years (Powder) |
| Tech. Data Sheet | View datasheet |
| Link To Supplier | http://www.medchemexpress.com |
| Shipping Details | Room Temperature |
| Material Safety Data Sheet | Download PDF |
